Page 9 - Nature Structural News Today

In humans, virtually every cell stores fat. However, patients with a rare condition called congenital lipodystrophy, which is often diagnosed in childhood, cann

Cannabis consumers who had used the drug 11 to 100 times or more were four to five years younger “when they developed cataracts than subjects who never used…

Nearly seventy years after the discovery of Amphotericin B, scientists are still learning from this enigmatic drug. New results challenge a long-standing paradigm for the drug's mechanism of action and suggest new avenues for drug development.

PSI scientists have shed light on an important component of the eye: a protein in the rod cells of the retina which helps us see in dim light. Acting

Current information from the Federal Administration. All press releases from the Federal Administration, the departments and offices.

Advanced molecular imaging technology has now mapped the structure of a drug widely used to treat fungal infections but whose workings have mystified researchers and physicians for nearly 70 years.In a new study, researchers at the University of Illi

EMBL researchers’ continued work with RNA polymerases provides fundamental information to understand enzyme mutations connected to rare diseases and

Illinois chemistry professor Martin Burke co-led a team that mapped the unusual aggregate structure of the antifungal drug amphotericin B

It's an old needlework trick, and a protein in our body knows it: Instead of threading yarn into the eye from the end, it can be easier to pass a loop through it.

A team of infectious disease advisers will soon look at the results of Merck's clinical trial and decide whether to recommend emergency use authorization for the first pill to treat early-stage COVID-19.